Oncology Hematology Care Inc — Cincinnati, Ohio

Public research footprint of Oncology Hematology Care Inc, compiled from the ClinicalTrials.gov public registry.

339

Registered studies

144

Active

Recruiting now

145

Completed

Stopped or withdrawn

Most-studied conditions

Acute Lymphoblastic Leukemia · Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Recurrent Ovarian Carcinoma

Recently updated registry entries

NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Oncology Hematology Care Inc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.